H2O AMERICA — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that H2O AMERICA filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $800.59M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $748.44M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $670.36M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $620.70M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $573.69M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $564.53M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $420.48M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $397.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $389.23M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $339.71M | Feb 27, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $805.59M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $736.33M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $678.17M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $586.92M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $559.57M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $549.27M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $447.72M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $389.30M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $381.78M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $328.25M | Feb 27, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.58M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $93.97M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $84.99M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $73.83M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $60.48M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $13.28M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $26.09M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $19.72M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $2.42M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | ($5.49M) | Mar 1, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $177.53M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $170.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $149.44M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $130.98M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $111.16M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $24.29M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $41.88M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $36.07M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $15.43M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $6.02M | Mar 1, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $244.80M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $195.53M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $190.83M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $166.20M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $130.04M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $104.05M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $130.01M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $91.34M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $101.11M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $114.57M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.15B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.66B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.35B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.76B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.49B | Feb 24, 2023 |
| FY2022 | Dec 31, 2020 | $3.31B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $3.13B | Feb 28, 2022 |
| FY2019 | Dec 31, 2018 | $1.96B | Mar 2, 2020 |
| FY2020 | Dec 31, 2017 | $1.96B | Mar 1, 2021 |
| FY2017 | Dec 31, 2016 | $1.44B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.37B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.23B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $1.11B | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $1.03B | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $917.16M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $889.98M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $889.31M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $463.21M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $421.65M | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $640.31M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $640.31M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $640.31M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $640.31M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $640.47M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $628.14M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $628.29M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.68M | Mar 2, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $581.08M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $537.18M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $495.38M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $458.36M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $428.26M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $408.04M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $383.19M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $393.92M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $376.12M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $338.39M | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.69M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $11.11M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $9.72M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $12.34M | Feb 23, 2024 |
| FY2023 | Dec 31, 2021 | $10.91M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $5.27M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $12.94M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $420.72M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $7.80M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $6.35M | Feb 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.90B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.72B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.58B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.49B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.52B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.35B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.29B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $435.00M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $435.00M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $437.72M | Feb 27, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36.12M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 33.63M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 32.02M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 30.80M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 30.18M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 28.56M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 28.46M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 28.40M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 20.52M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 20.46M | Feb 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.65M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $52.13M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $47.91M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $43.58M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $40.14M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $36.51M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $34.13M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $23.07M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $21.33M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $16.56M | Feb 27, 2019 |